Module 6 - Applying MIDD Strategies to Decision-Making

  Рет қаралды 458

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Күн бұрын

Dr. Mark R. Gasronguay, Founder and CEO of the Metrum Research Group, discusses how to use simulation from a mathematical model to evaluate scenarios and explore different decision paths. He wraps up with some assumption checking and additional examples of MIDD in practice.
This module is part of the educational series “Model-Informed Drug Development (MIDD): Methods Advancing Medical Products to Patients”. The educational content was developed for regulatory scientists by experts in the field in partnership with the Critical Path Institute and funded by FDA CDER Office of Translational Sciences. As part of Multidisciplinary Education and Exchange initiatives, CDER’s Quantitative Medicine Center of Excellence is making this resource accessible to all, supporting community-wide educational enrichment.
Disclaimer: The presentations in this educational series reflect the views of the presenters and should not be construed to represent FDA’s views or policies.

Пікірлер
Module 7 - Case Study 1: Optimizing CERA Pediatric Drug Development
8:00
U.S. Food and Drug Administration
Рет қаралды 201
MIDD Training Module 2 - Part Two
55:26
U.S. Food and Drug Administration
Рет қаралды 269
VAMPIRE DESTROYED GIRL???? 😱
00:56
INO
Рет қаралды 8 МЛН
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 1 - Part 1
1:33:53
ICH M12 Drug-Drug Interaction Studies Final Guidance
1:54:10
U.S. Food and Drug Administration
Рет қаралды 96
Global IDMP Implementation - Getting Closer to the Goal
1:25:26
U.S. Food and Drug Administration
Рет қаралды 48
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 2 - Part 2
1:39:03
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 1 - Part 4
1:01:38
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 2 - Part 1
1:31:22
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 1 - Part 2
1:12:08
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 2 - Part 3
1:52:53
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 1 - Part 3
1:17:23
Biosimilars: Totality of the Evidence in Biosimilar Development
6:32
U.S. Food and Drug Administration
Рет қаралды 319